560 related articles for article (PubMed ID: 15454139)
1. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
2. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification.
Zogakis TG; Wetherille RE; Christensen RD; Ose KJ; Friedman JD; Colbert M; Svendsen CA; Sanan OK; Tuttle TM
Ann Surg Oncol; 2005 Feb; 12(2):167-72. PubMed ID: 15827798
[TBL] [Abstract][Full Text] [Related]
4. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.
Chagpar A; Martin RC; Chao C; Wong SL; Edwards MJ; Tuttle T; McMasters KM
Arch Surg; 2004 Jun; 139(6):614-8; discussion 618-20. PubMed ID: 15197087
[TBL] [Abstract][Full Text] [Related]
5. Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience.
Feezor RJ; Kasraeian A; Copeland EM; Schell SR; Hochwald SN; Cendan J; Drane W; Mastin S; Wilkinson E; Lind DS
Am Surg; 2002 Aug; 68(8):684-7; discussion 687-8. PubMed ID: 12206602
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
[TBL] [Abstract][Full Text] [Related]
7. Effect of massage technique on sentinel lymph node mapping for cancer of the breast.
Haynes G; Garske D; Case D; Shen P; Levine EA; Perrier ND
Am Surg; 2003 Jun; 69(6):520-2. PubMed ID: 12852511
[TBL] [Abstract][Full Text] [Related]
8. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer.
Martin RC; Derossis AM; Fey J; Yeung H; Yeh SD; Akhurst T; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
Surgery; 2001 Sep; 130(3):432-8. PubMed ID: 11562666
[TBL] [Abstract][Full Text] [Related]
9. A validation trial of subdermal injection compared with intraparenchymal injection for sentinel lymph node biopsy in breast cancer.
Vargas HI; Tolmos J; Agbunag RV; Mishkin F; Vargas MP; Diggles L; Gonzalez KD; Venegas R; Klein SR; Khalkhali I
Am Surg; 2002 Jan; 68(1):87-91. PubMed ID: 12467326
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.
Eldrageely K; Vargas MP; Khalkhali I; Venegas R; Burla M; Gonzalez KD; Vargas HI
Am Surg; 2004 Oct; 70(10):872-5. PubMed ID: 15529840
[TBL] [Abstract][Full Text] [Related]
11. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer.
Kaklamanos IG; Birbas K; Syrigos K; Bonatsos VG; Bonatsos G
J Surg Oncol; 2011 Jul; 104(1):37-40. PubMed ID: 21360537
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques.
Pelosi E; Bellò M; Giors M; Ala A; Giani R; Bussone R; Bisi G
J Nucl Med; 2004 Feb; 45(2):220-5. PubMed ID: 14960639
[TBL] [Abstract][Full Text] [Related]
14. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
15. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.
King TA; Fey JV; Van Zee KJ; Heerdt AS; Gemignani ML; Port ER; Sclafani L; Sacchini V; Petrek JA; Cody HS; Borgen PI; Montgomery LL
Ann Surg Oncol; 2004 May; 11(5):535-41. PubMed ID: 15123464
[TBL] [Abstract][Full Text] [Related]
16. [Sentinel lymph node detection in patients with early-stage breast cancer: which site of injection in 2011?].
Frati A; Delpech Y; Bricou A; Barranger E
Gynecol Obstet Fertil; 2011 Nov; 39(11):620-3. PubMed ID: 21873098
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer.
Usmani S; Khan HA; abu Huda F; Ahmed N; al Nafisi N; Marafi F; al Mohannadi S; Javed A; Amanguno HG; Al Saleh N
Hell J Nucl Med; 2010; 13(1):30-4. PubMed ID: 20411168
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intradermal and subcutaneous injections in lymphatic mapping.
Kersey TW; Van Eyk J; Lannin DR; Chua AN; Tafra L
J Surg Res; 2001 Apr; 96(2):255-9. PubMed ID: 11266281
[TBL] [Abstract][Full Text] [Related]
19. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
[TBL] [Abstract][Full Text] [Related]
20. [Validation of sentinel node in breast cancer].
Vergara-Fernández O; Cortés-González R; Medina-Franco H
Rev Invest Clin; 2004; 56(3):309-13. PubMed ID: 15612512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]